Patel named different kind of ‘Rockstar’

He may not be a rock star on stage, but the University of Illinois College of Medicine considers Pritesh Patel one with his patients.The Department of Medicine annually recognizes one faculty member from each division as a “Divisional Rockstar” for their contributions to the department. Patel, MD, associate director of the Blood & Marrow Transplant (BMT) program in the division of hematology and oncology and member of the UI Cancer Center’s Translational Oncology…

Continue Reading

Gadi joining ACS panel discussing immunotherapy and cancer care

The rise in immunotherapy cancer treatments are a major factor why cancer mortality rates have experienced a 30% drop since 1991, according to the American Cancer Society’s Cancer Facts and Figures reports.V.K. Gadi, MD, PhD, associate director for Translational Oncology Medicine at the UI Cancer Center, will be a panelist discussing how immunotherapy is revolutionizing cancer care and how it influences a patient’s experience. The free Zoom event, sponsored by the American Cancer Society’s…

Continue Reading

Jain answers questions about COVID-19

Shikha Jain, MD, FACP, assistant professor of hematology/oncology at the College of Medicine, Director of Communication Strategies in Medicine, and Associate Director of Oncology Communication & Digital Innovation, returned to Fox Channel 32’s Good Day Chicago last week to answer commonly asked questions about coronavirus testing. View here

Continue Reading

Stewart and Watson featured on NBC Chicago

“Screening saves lives.” That was the message UI Cancer Center members John Stewart IV, MD, MBA, FACS, associate director of clinical research, and Karriem Watson, DHSc, MS, MPH, associate director of community outreach and engagement and director of community based research at Mile Square Health Center, told WMAQ Ch. 5 viewers during an interview about young adults undergoing colon cancer screening. View here

Continue Reading

Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective

A new type of breast cancer drug developed by University of Illinois Cancer Center members Debra Tonetti and Gregory Thatcher can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy. The results are published in the journal Breast Cancer Research and Treatment. Breast cancer affects one in eight women in the United…

Continue Reading

Jain featured in CCF videos

University of Illinois Cancer Center member Shikha Jain, MD, FACP, assistant professor of hematology/oncology at the College of Medicine, Director of Communication Strategies in Medicine, and Associate Director of Oncology Communication & Digital Innovation, is featured in a new video developed by the Carcinoid Cancer Foundation (CCF). The video, titled “Carcinoid Syndrome and Serotonin,” explains carcinoid syndrome and why it occurs, how it can be confused with other health conditions, its impact on…

Continue Reading

Jain discusses colon cancer following death of actor Boseman

Colon cancer, the second leading cause of cancer death in the United States, claimed the life of 43-year-old actor Chadwick Boseman (“Black Panther,” “42,” among others) on Friday, August 28. The American Cancer Society (ACS) estimates that 147,950 new cases of colorectal cancer will be diagnosed in 2020, with 53,200 people dying from the disease. Blacks have the highest rates of colorectal cancer in any racial/ethnic group in the United States, and an…

Continue Reading

DOD grant trying to close gap between Black and white men with prostate cancer

Larisa Nonn has received a grant from the U.S. Department of Defense to understand why a large gap exists between Black and white men being diagnosed with prostate cancer. Black men contract the disease at a younger age, the growth is more aggressive in nature, and causes twice as many deaths.  “Given the younger age and more aggressive the disease, it is likely there are biological underpinnings of prostate cancer distinct in African…

Continue Reading

Zenk chosen to lead National Institute of Nursing Research

University of Illinois Cancer Center member Shannon Zenk has been selected by the National Institutes of Health to lead its National Institute of Nursing Research, or NINR. Zenk, PhD, MPH, RN, Nursing Collegiate Professor at the UIC College of Nursing and member of the UI Cancer Center’s Cancer Prevention and Control Program, is expected to join the NINR in the fall.“Dr. Zenk’s diverse and original research experience paired with her expertise as a…

Continue Reading